REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway.
Animals
Carcinoma, Pancreatic Ductal
/ metabolism
Cell Line, Tumor
Humans
MAP Kinase Signaling System
Male
Metaplasia
/ metabolism
Mice, Inbred C57BL
N-Acetylglucosaminyltransferases
/ analysis
Pancreatic Ducts
/ metabolism
Pancreatic Neoplasms
/ metabolism
Pancreatitis-Associated Proteins
/ analysis
Signal Transduction
Tumor Cells, Cultured
raf Kinases
/ metabolism
ras Proteins
/ metabolism
Pancreatic Neoplasms
Journal
Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179
Informations de publication
Date de publication:
07 06 2021
07 06 2021
Historique:
received:
19
12
2019
accepted:
07
05
2021
entrez:
8
6
2021
pubmed:
9
6
2021
medline:
12
8
2021
Statut:
epublish
Résumé
Persistent acinar to ductal metaplasia (ADM) is a recently recognized precursor of pancreatic ductal adenocarcinoma (PDAC). Here we show that the ADM area of human pancreas tissue adjacent to PDAC expresses significantly higher levels of regenerating protein 3A (REG3A). Exogenous REG3A and its mouse homolog REG3B induce ADM in the 3D culture of primary human and murine acinar cells, respectively. Both Reg3b transgenic mice and REG3B-treated mice with caerulein-induced pancreatitis develop and sustain ADM. Two out of five Reg3b transgenic mice with caerulein-induced pancreatitis show progression from ADM to pancreatic intraepithelial neoplasia (PanIN). Both in vitro and in vivo ADM models demonstrate activation of the RAS-RAF-MEK-ERK signaling pathway. Exostosin-like glycosyltransferase 3 (EXTL3) functions as the receptor for REG3B and mediates the activation of downstream signaling proteins. Our data indicates that REG3A/REG3B promotes persistent ADM through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway. Targeting REG3A/REG3B, its receptor EXTL3, or other downstream molecules could interrupt the ADM process and prevent early PDAC carcinogenesis.
Identifiants
pubmed: 34099862
doi: 10.1038/s42003-021-02193-z
pii: 10.1038/s42003-021-02193-z
pmc: PMC8184755
doi:
Substances chimiques
EXTL3 protein, human
0
Extl3 protein, mouse
0
Pancreatitis-Associated Proteins
0
REG3A protein, human
0
Reg3b protein, mouse
0
N-Acetylglucosaminyltransferases
EC 2.4.1.-
raf Kinases
EC 2.7.11.1
ras Proteins
EC 3.6.5.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
688Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : CIHR
ID : PJ9-173593
Pays : Canada
Organisme : CIHR
ID : PJT-175208
Pays : Canada
Références
Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S40-3
pubmed: 19896097
Int J Cardiol. 2018 May 1;258:7-13
pubmed: 29544958
J Pathol. 2017 Sep;243(1):65-77
pubmed: 28639695
Mol Med. 2015 May;20(1):548-558
pubmed: 25826674
Int J Cancer. 2010 Oct 15;127(8):1795-803
pubmed: 20099282
Biochem Biophys Res Commun. 2009 May 8;382(3):561-5
pubmed: 19292977
Development. 2005 Aug;132(16):3767-76
pubmed: 16020518
Oncogene. 2007 May 14;26(22):3279-90
pubmed: 17496922
Cancer Sci. 2012 Dec;103(12):2082-91
pubmed: 22957785
Gut. 2012 Dec;61(12):1723-32
pubmed: 22271799
Cancer Res. 2011 Jul 15;71(14):5020-9
pubmed: 21586612
Oncoimmunology. 2013 Nov 1;2(11):e26404
pubmed: 24353919
Immunity. 2012 Jul 27;37(1):74-84
pubmed: 22727489
Gastroenterology. 2014 Nov;147(5):1106-18.e11
pubmed: 25128759
Cell Rep. 2016 Mar 15;14(10):2325-36
pubmed: 26947075
Cell Mol Gastroenterol Hepatol. 2017 May 31;4(2):263-282
pubmed: 28752115
J Hepatobiliary Pancreat Surg. 2007;14(3):224-32
pubmed: 17520196
J Mol Med (Berl). 2014 Dec;92(12):1257-69
pubmed: 24996521
Adv Anat Pathol. 2005 Mar;12(2):81-91
pubmed: 15731576
Gut. 2014 Apr;63(4):656-64
pubmed: 23645620
J Biol Chem. 2012 Feb 10;287(7):4726-39
pubmed: 22158612
Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E669-80
pubmed: 21245462
Oncotarget. 2016 Nov 22;7(47):77838-77853
pubmed: 27788482
Cell Mol Life Sci. 2017 Nov;74(22):4231-4243
pubmed: 28656348
World J Gastroenterol. 2016 Aug 21;22(31):7046-57
pubmed: 27610015
Oncogene. 2013 Apr 11;32(15):1950-8
pubmed: 22665051
Cancer Cell. 2007 Mar;11(3):291-302
pubmed: 17349585
J Clin Invest. 2010 Feb;120(2):508-20
pubmed: 20071774
Gut. 2018 Jan;67(1):146-156
pubmed: 27646934
Cell Mol Gastroenterol Hepatol. 2017 Jan;3(1):99-118
pubmed: 28090569
J Biol Chem. 2000 Apr 14;275(15):10723-6
pubmed: 10753861
Biomed Res Int. 2014;2014:474905
pubmed: 24783207
FEBS Lett. 2002 Oct 23;530(1-3):59-64
pubmed: 12387866
Cancer Lett. 2015 Jun 28;362(1):45-60
pubmed: 25779676
Gastroenterology. 2014 Mar;146(3):822-834.e7
pubmed: 24315826
Gene. 2016 Mar 10;578(2):263-73
pubmed: 26719042
Nat Rev Gastroenterol Hepatol. 2017 May;14(5):296-304
pubmed: 28270694
Nat Commun. 2016 Nov 10;7:13393
pubmed: 27830702
Gastroenterology. 2016 Sep;151(3):526-39
pubmed: 27215660
Cancer Res. 2015 Nov 15;75(22):4852-62
pubmed: 26404002
Gastroenterology. 2013 Jun;144(6):1180-93
pubmed: 23622127
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29229669
J Gastroenterol. 2010;45(1):52-9
pubmed: 19789838
Biochim Biophys Acta. 2001 Apr 16;1518(3):287-93
pubmed: 11311942
Biomol Concepts. 2012 Feb;3(1):57-70
pubmed: 22582090
Int J Cancer. 2012 Sep 1;131(5):1243-8
pubmed: 22024988
Cancer. 2014 Nov 15;120(22):3446-56
pubmed: 24948110
J Cell Biol. 2013 Aug 5;202(3):563-77
pubmed: 23918941
Cancer Res. 2013 Sep 15;73(18):5682-94
pubmed: 23867474
Gastroenterology. 2005 Mar;128(3):728-41
pubmed: 15765408
Am J Pathol. 2007 Jul;171(1):263-73
pubmed: 17591971
Gut. 2007 Aug;56(8):1134-52
pubmed: 17625148
J Surg Res. 2002 Jun 15;105(2):136-44
pubmed: 12121700